Rankings
▼
Calendar
PRTA Q4 2019 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena
PRTA
Prothena Corporation plc
$512M
Q4 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$256,000
+32.0% YoY
Gross Profit
-$15M
-5943.4% margin
Operating Income
-$23M
-9091.4% margin
Net Income
-$22M
-8419.5% margin
EPS (Diluted)
$-0.54
QoQ Revenue Growth
+24.9%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$15M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$419M
Total Liabilities
$146M
Stockholders' Equity
$273M
Cash & Equivalents
$376M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$256,000
$194,000
+32.0%
Gross Profit
-$15M
-$16M
+6.7%
Operating Income
-$23M
-$23M
-2.3%
Net Income
-$22M
-$22M
+4.0%
← FY 2019
All Quarters
Q1 2020 →